A combined preclinical therapy of cannabinoids and temozolomide against glioma.
about
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsTargeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesAnticancer mechanisms of cannabinoidsEndocannabinoids as Guardians of MetastasisLipid metabolic reprogramming in cancer cellsCannabinoids as therapeutic agents in cancer: current status and future implicationsAutophagy in malignant transformation and cancer progressionTargeting autophagy to sensitive glioma to temozolomide treatmentPreclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsHonokiol-induced apoptosis and autophagy in glioblastoma multiforme cellsCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effectA user's guide to cannabinoid therapies in oncologyThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Marijuana: respiratory tract effects.Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.Cannabidiol as potential anticancer drug.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87.Autophagy in brain tumors: a new target for therapeutic intervention.Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling PathwayCannabidiol inhibits angiogenesis by multiple mechanisms.Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.Integrating cannabis into clinical cancer care.Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.Cannabis, a complex plant: different compounds and different effects on individuals.Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.The evolving role of the endocannabinoid system in gynaecological cancer.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.The Use of Medical Marijuana in Cancer.Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cellsCannabinoid signaling in health and disease.
P2860
Q24622202-7BEC1A94-5A0D-4B08-9324-FFACC356CC9AQ24623282-EAD2FAB7-E27C-436A-A667-23ECB7B6A039Q26750399-7D3CFC85-6703-4806-AF79-704473677DCEQ26766163-F126FA0F-5C3D-46E1-9937-F208D7B5B875Q26774859-4FA69EF8-A0CE-412B-9865-C05EB9FE629CQ26866298-5292CBA7-892B-4694-BCE5-5B010826CBFDQ27000191-9588E4F1-1EA5-4E82-A2F8-F845FD454F3DQ28066270-71D96708-75BF-44A7-BD48-F7BA44E41466Q28075903-2467C8FC-C3C0-4309-83DD-C6FAECD16D56Q28301209-F70C042B-9431-43F4-AD2F-21C8D51509F6Q28534561-5DDE53C8-FED2-4A9A-8ECA-C217AFA3A504Q28818800-996100D4-166B-4254-8435-4BAFF6002D8BQ33623423-1AE51905-2C7A-4F97-8464-33546E83C808Q34347280-EC31F281-AFCF-4C2C-B2D3-8F9530E2026DQ34402827-B8C01275-9A73-4ABD-AE6E-2173FA0F9B67Q34437996-F3E9DF7A-6494-4F1E-AE9E-2B8CCD98BEE1Q34563482-6A8ABA9F-2EB4-44B1-A834-E2AF990D8A9DQ34637516-B69C671C-A7F4-4E30-944A-78DF6655183CQ34669534-76784DE2-B4F5-446E-B686-20EC18502847Q35056313-78248DFE-CF31-4DC7-B080-483F8444161CQ35624780-57CAB9BD-0FEC-498D-B287-56466B51ACE2Q36085919-F20A8847-58E8-4CB7-9E95-99D605E44540Q36247757-CC17525A-B5EC-4D8C-840B-32526255C6D5Q36419293-6C831BC7-CA90-42F2-8C77-B9C6AF9E68FBQ36612284-C737B2F3-9F04-4E8E-BAE1-10BA08968B64Q36685151-4161DF5D-229C-4B56-8173-575EF545DD0FQ37299613-3D22AC2C-F5AD-4854-8BC2-14398D8D8C74Q38132167-62221FB8-ACE0-49B7-8D19-B1AA1C3F4330Q38154188-36E7B0D0-A6AE-47BD-AFC7-0E39F371440FQ38351132-8A401EBC-4DFF-4C0F-9B24-ABFDE773CE70Q38469671-78B48699-D96C-4D93-90C6-3BA9B81D8C04Q38503842-BD2C4043-186B-4A55-9CE6-EF8B2C31E250Q38692926-4534F027-C09D-4DAC-A351-0221B1595ED0Q38709774-7F15E28E-1A5E-4FBE-B1BE-34BC3C160D1FQ38732473-8FD87815-AD90-4606-83C6-80BDED5F1027Q38842133-4FC073E9-5A48-474D-9EC7-C685F1E9A8E1Q38883388-AD711E69-0BA4-48BD-AA20-97944E8F5CE5Q38889500-069A0C04-B1BC-4C1C-9950-BB0DF1061C3FQ39136340-BEA3FFB8-BE50-4F23-B6B2-5051F5EA9C04Q39163671-9C37764A-DB18-40AF-8D15-27AEB69B4465
P2860
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@ast
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@en
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@nl
type
label
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@ast
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@en
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@nl
prefLabel
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@ast
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@en
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@nl
P2093
P50
P1476
A combined preclinical therapy of cannabinoids and temozolomide against glioma.
@en
P2093
Elena García-Taboada
Fátima Rodríguez-Fornés
Manuel Guzmán
Mar Lorente
Sonia Hernández-Tiedra
P304
P356
10.1158/1535-7163.MCT-10-0688
P577
2011-01-01T00:00:00Z